Skip to main content
ENALAPRILAT 1.25 mg/mL injection by HF Acquisition Co LLC, DBA HealthFirst
ENALAPRILAT, 1.25 mg/mL, injection Drug class: Angiotensin Converting Enzyme Inhibitor. Available on prescription only. Listed by HF Acquisition Co LLC, DBA HealthFirst.
Prescription only Generic

ENALAPRILAT

Listed by HF Acquisition Co LLC, DBA HealthFirst

Strength
1.25 mg/mL
Form
Injection
Route
Intravenous
Class
Angiotensin Converting Enzyme Inhibitor

What it contains

  • Enalaprilat 1.25 mg/mL

FDA record

Dosage form Injection
Route Intravenous
Drug class Angiotensin Converting Enzyme Inhibitor
Approval route ANDA — approved generic
NDC code 51662-1477
FDA application ANDA078687
RxNorm concept 1729200
Package sizes listed 1
Marketed since February 2020

Other products containing Enalaprilat

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Enalaprilat

Strength
2.5 mg/2mL
Form
Injection
Class
Angiotensin Converting Enzyme Inhibitor
Rx only Generic

Hikma Pharmaceuticals USA Inc.

Not stocked by us — reference only

Enalaprilat

Strength
1.25 mg/mL
Form
Injection
Class
Angiotensin Converting Enzyme Inhibitor
Rx only Generic

Hikma Pharmaceuticals USA Inc.

Not stocked by us — reference only

Enalaprilat

Strength
1.25 mg/mL
Form
Injection
Class
Angiotensin Converting Enzyme Inhibitor
Rx only Generic

Dr. Reddys Laboratories Inc

Not stocked by us — reference only

Enalaprilat

Strength
2.5 mg/2mL
Form
Injection
Class
Angiotensin Converting Enzyme Inhibitor
Rx only Generic

Dr. Reddys Laboratories Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.